Immunotherapy of human papilloma virus induced disease
- PMID: 23341861
- PMCID: PMC3547504
- DOI: 10.2174/1874357901206010257
Immunotherapy of human papilloma virus induced disease
Abstract
Immunotherapy is the generic name for treatment modalities aiming to reinforce the immune system against diseases in which the immune system plays a role. The design of an optimal immunotherapeutic treatment against chronic viruses and associated diseases requires a detailed understanding of the interactions between the target virus and its host, in order to define the specific strategies that may have the best chance to deliver success at each stage of disease. Recently, a first series of successes was reported for the immunotherapy of Human Papilloma Virus (HPV)-induced premalignant diseases but there is definitely room for improvement. Here I discuss a number of topics that in my opinion require more study as the answers to these questions allows us to better understand the underlying mechanisms of disease and as such to tailor treatment.
Keywords: CD4 T cells; Innate immune signaling; adoptive cell transfer.; cervical cancer; interferon-gamma; macrophages; oropharyngeal cancer.
Similar articles
-
Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients.Cytotherapy. 2018 Mar;20(3):385-393. doi: 10.1016/j.jcyt.2017.11.010. Epub 2018 Jan 10. Cytotherapy. 2018. PMID: 29331266 Free PMC article.
-
Immunotherapy against cancer-related viruses.Cell Res. 2017 Jan;27(1):59-73. doi: 10.1038/cr.2016.153. Epub 2016 Dec 23. Cell Res. 2017. PMID: 28008927 Free PMC article. Review.
-
Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer.Int J Cancer. 2005 Mar 20;114(2):274-82. doi: 10.1002/ijc.20721. Int J Cancer. 2005. PMID: 15540211
-
The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.FASEB J. 2021 Mar;35(3):e21401. doi: 10.1096/fj.202000528RR. FASEB J. 2021. PMID: 33559190
-
Targeting HPV in gynaecological cancers - Current status, ongoing challenges and future directions.Womens Health (Lond). 2020 Jan-Dec;16:1745506520961709. doi: 10.1177/1745506520961709. Womens Health (Lond). 2020. PMID: 33296284 Free PMC article. Review.
Cited by
-
The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications.Ann Transl Med. 2016 May;4(9):173. doi: 10.21037/atm.2016.03.34. Ann Transl Med. 2016. PMID: 27275486 Free PMC article. Review.
-
ONCOGENIC HUMAN PAPILLOMAVIRUSES: High-Risk Human Papillomaviruses: Towards a Better Understanding of the Mechanisms of Viral Transformation, Latency and Immune-Escape.Open Virol J. 2012;6:160-2. doi: 10.2174/1874357901206010160. Epub 2012 Dec 28. Open Virol J. 2012. PMID: 23346264 Free PMC article. No abstract available.
-
Tailored immunotherapy for HPV positive head and neck squamous cell cancer.Oral Oncol. 2014 Sep;50(9):780-4. doi: 10.1016/j.oraloncology.2013.09.010. Epub 2013 Oct 11. Oral Oncol. 2014. PMID: 24126224 Free PMC article.
-
Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.J Immunol Res. 2018 May 2;2018:2912671. doi: 10.1155/2018/2912671. eCollection 2018. J Immunol Res. 2018. PMID: 29854832 Free PMC article. Review.
References
-
- Van der Burg SH, Arens R, Melief CJ. Immunotherapy for persistent viral infections and associated disease. Trends Immunol . 2011; 32:97–103. - PubMed
-
- Van der Burg SH, Melief CJ. Therapeutic vaccination against human papilloma virus induced malignancies. Curr Opin Immunol . 2011; 23:252–7. - PubMed
-
- De Jong A, van Poelgeest MI, van der Hulst JM, et al. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res. 2004; 64:5449–55. - PubMed
-
- Nakagawa M, Stites DP, Farhat S, et al. Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis. 1997; 175:927–31. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials